Get started
Author

Xiaohua Zhou

Observed name: X. Zhou
ORCID: 0009-0009-2208-9679
Observed ORCID: 0009-0009-2208-9679
OpenAlex ID: A5006039654
B7-H3–Targeting Chimeric Antigen Receptors Epstein-Barr Virus–specific T Cells Provides a Tumor Agnostic Off-The-Shelf Therapy Against B7-H3–positive Solid Tumors
2024 · Siok Ping Yeo, Lindsay Kua, et al. · Cancer Research Communications · 6
Discovery and development of small-molecule inhibitors targeting cytotoxic T lymphocyte associated protein 4 to enhance cancer immunotherapy and reduce side effects
2026 · Chong Yu, Xiaohua Zhou, et al. · International Immunopharmacology
Supplementary figure 3 from B7-H3–Targeting Chimeric Antigen Receptors Epstein-Barr Virus–specific T Cells Provides a Tumor Agnostic Off-The-Shelf Therapy Against B7-H3–positive Solid Tumors
2024 · Siok Ping Yeo, Lindsay Kua, et al.
FIGURE 5 from B7-H3–Targeting Chimeric Antigen Receptors Epstein-Barr Virus–specific T Cells Provides a Tumor Agnostic Off-The-Shelf Therapy Against B7-H3–positive Solid Tumors
2024 · Siok Ping Yeo, Lindsay Kua, et al.
FIGURE 6 from B7-H3–Targeting Chimeric Antigen Receptors Epstein-Barr Virus–specific T Cells Provides a Tumor Agnostic Off-The-Shelf Therapy Against B7-H3–positive Solid Tumors
2024 · Siok Ping Yeo, Lindsay Kua, et al.
FIGURE 1 from B7-H3–Targeting Chimeric Antigen Receptors Epstein-Barr Virus–specific T Cells Provides a Tumor Agnostic Off-The-Shelf Therapy Against B7-H3–positive Solid Tumors
2024 · Siok Ping Yeo, Lindsay Kua, et al.
Table S1 from B7-H3–Targeting Chimeric Antigen Receptors Epstein-Barr Virus–specific T Cells Provides a Tumor Agnostic Off-The-Shelf Therapy Against B7-H3–positive Solid Tumors
2024 · Siok Ping Yeo, Lindsay Kua, et al.
Table S1 from B7-H3–Targeting Chimeric Antigen Receptors Epstein-Barr Virus–specific T Cells Provides a Tumor Agnostic Off-The-Shelf Therapy Against B7-H3–positive Solid Tumors
2024 · Siok Ping Yeo, Lindsay Kua, et al.
Supplementary figure 7 from B7-H3–Targeting Chimeric Antigen Receptors Epstein-Barr Virus–specific T Cells Provides a Tumor Agnostic Off-The-Shelf Therapy Against B7-H3–positive Solid Tumors
2024 · Siok Ping Yeo, Lindsay Kua, et al.
Supplementary figure 8 from B7-H3–Targeting Chimeric Antigen Receptors Epstein-Barr Virus–specific T Cells Provides a Tumor Agnostic Off-The-Shelf Therapy Against B7-H3–positive Solid Tumors
2024 · Siok Ping Yeo, Lindsay Kua, et al.
Supplementary Data from B7-H3–Targeting Chimeric Antigen Receptors Epstein-Barr Virus–specific T Cells Provides a Tumor Agnostic Off-The-Shelf Therapy Against B7-H3–positive Solid Tumors
2024 · Siok Ping Yeo, Lindsay Kua, et al.
Supplementary figure 2 from B7-H3–Targeting Chimeric Antigen Receptors Epstein-Barr Virus–specific T Cells Provides a Tumor Agnostic Off-The-Shelf Therapy Against B7-H3–positive Solid Tumors
2024 · Siok Ping Yeo, Lindsay Kua, et al.
FIGURE 7 from B7-H3–Targeting Chimeric Antigen Receptors Epstein-Barr Virus–specific T Cells Provides a Tumor Agnostic Off-The-Shelf Therapy Against B7-H3–positive Solid Tumors
2024 · Siok Ping Yeo, Lindsay Kua, et al.
Supplementary figure 1 from B7-H3–Targeting Chimeric Antigen Receptors Epstein-Barr Virus–specific T Cells Provides a Tumor Agnostic Off-The-Shelf Therapy Against B7-H3–positive Solid Tumors
2024 · Siok Ping Yeo, Lindsay Kua, et al.
FIGURE 8 from B7-H3–Targeting Chimeric Antigen Receptors Epstein-Barr Virus–specific T Cells Provides a Tumor Agnostic Off-The-Shelf Therapy Against B7-H3–positive Solid Tumors
2024 · Siok Ping Yeo, Lindsay Kua, et al.
Supplementary figure 5 from B7-H3–Targeting Chimeric Antigen Receptors Epstein-Barr Virus–specific T Cells Provides a Tumor Agnostic Off-The-Shelf Therapy Against B7-H3–positive Solid Tumors
2024 · Siok Ping Yeo, Lindsay Kua, et al.
Supplementary figure 6 from B7-H3–Targeting Chimeric Antigen Receptors Epstein-Barr Virus–specific T Cells Provides a Tumor Agnostic Off-The-Shelf Therapy Against B7-H3–positive Solid Tumors
2024 · Siok Ping Yeo, Lindsay Kua, et al.
Supplementary figure 4 from B7-H3–Targeting Chimeric Antigen Receptors Epstein-Barr Virus–specific T Cells Provides a Tumor Agnostic Off-The-Shelf Therapy Against B7-H3–positive Solid Tumors
2024 · Siok Ping Yeo, Lindsay Kua, et al.
FIGURE 6 from B7-H3–Targeting Chimeric Antigen Receptors Epstein-Barr Virus–specific T Cells Provides a Tumor Agnostic Off-The-Shelf Therapy Against B7-H3–positive Solid Tumors
2024 · Siok Ping Yeo, Lindsay Kua, et al.
FIGURE 4 from B7-H3–Targeting Chimeric Antigen Receptors Epstein-Barr Virus–specific T Cells Provides a Tumor Agnostic Off-The-Shelf Therapy Against B7-H3–positive Solid Tumors
2024 · Siok Ping Yeo, Lindsay Kua, et al.
FIGURE 2 from B7-H3–Targeting Chimeric Antigen Receptors Epstein-Barr Virus–specific T Cells Provides a Tumor Agnostic Off-The-Shelf Therapy Against B7-H3–positive Solid Tumors
2024 · Siok Ping Yeo, Lindsay Kua, et al.
FIGURE 3 from B7-H3–Targeting Chimeric Antigen Receptors Epstein-Barr Virus–specific T Cells Provides a Tumor Agnostic Off-The-Shelf Therapy Against B7-H3–positive Solid Tumors
2024 · Siok Ping Yeo, Lindsay Kua, et al.
FIGURE 8 from B7-H3–Targeting Chimeric Antigen Receptors Epstein-Barr Virus–specific T Cells Provides a Tumor Agnostic Off-The-Shelf Therapy Against B7-H3–positive Solid Tumors
2024 · Siok Ping Yeo, Lindsay Kua, et al.
FIGURE 7 from B7-H3–Targeting Chimeric Antigen Receptors Epstein-Barr Virus–specific T Cells Provides a Tumor Agnostic Off-The-Shelf Therapy Against B7-H3–positive Solid Tumors
2024 · Siok Ping Yeo, Lindsay Kua, et al.
FIGURE 4 from B7-H3–Targeting Chimeric Antigen Receptors Epstein-Barr Virus–specific T Cells Provides a Tumor Agnostic Off-The-Shelf Therapy Against B7-H3–positive Solid Tumors
2024 · Siok Ping Yeo, Lindsay Kua, et al.
Works count: 29
Citation count: 6
H-index: 1
I10-index:
Year
Topic
Type